<p>Silence Therapeutics plc has appointed Rhonda Hellums, the company’s Executive Vice President and Chief Financial Officer, to its Board of Directors effective immediately. Hellums will serve as an executive director until the company’s 2026 Annual General Meeting of Shareholders. She will not serve on any board committees. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silence Therapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-327575), on December 22, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

<p>Silence Therapeutics plc has appointed Rhonda Hellums, the company's Executive Vice President and Chief Financial Officer, to its Board of Directors effective immediately. Hellums will serve as an executive director until the company's 2026 Annual General Meeting of Shareholders. She will not serve on any board committees.</p>

Silence Therapeutics Appoints CFO Rhonda Hellums to Board